Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for AD

This funding opportunity invites applications that integrate the use of computational approaches to identify individual drugs currently used for other conditions with potential to be efficacious in AD or AD-related dementias (as single drugs or as drug combinations) with proof-of-concept efficacy studies in cell-based models, animal models and/or humans.


Visit funding web page